Goldman Sachs Report Warns Pharma Companies That Curing Disease Is Bad For Business

“There has always been some suspicion that pharmaceutical companies would rather keep people sick and on drugs than cure them in one shot and lose the ability to create return customers.”

Truther's World

A report from Goldman Sachs openly admitted that curing patients is not a “sustainable business model” for drug companies.

There has always been some suspicion that pharmaceutical companies would rather keep people sick and on drugs than cure them in one shot and lose the ability to create return customers.

Although the massive motive here is easy to see, with the industry bringing in over $453 billion in the United States alone in 2017, many people have a hard time considering that these companies don’t have their customers’ best interest at heart.

The idea that these companies would want to keep us sick is dismissed by many as a “conspiracy theory,” but let’s not forget that these companies and their high-level investors are here to sell drugs, not save lives. This point was brought up openly earlier this month in a memo that Goldman Sachs…

View original post 701 more words

2 thoughts on “Goldman Sachs Report Warns Pharma Companies That Curing Disease Is Bad For Business

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s